EUVIMEDEUVIMED entdecken
Crossref

How Industrial Policy Could Accelerate Innovation In The Life Sciences

James C Robinson

Health Affairs · 2023

DOI: 10.1377/hlthaff.2023.00047 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Health Affairs, 2023. Verfasst von James C Robinson. Beteiligte Einrichtung: James C. Robinson (james.robinson@berkeley.edu), University of California Berkeley, Berkeley, California. Hauptthemen laut MEDLINE: COVID-19, Biological Science Disciplines. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The US is expanding public investment in the technology-based industries, including the life sciences, in a move driven by anger, fear, and hope. Anger at high drug prices is leading to downward pressures and eroding traditional private-sector funding for research and development, fear of China's technological and political ambitions is creating bipartisan support for intervention, and the successful development of COVID-19 vaccines has spurred hope for analogous publicly funded breakthroughs in other therapeutic domains. The instruments of industrial policy used by other nations include grants for scientific research, equity investments in start-ups, tax incentives for corporate research and development, credit guarantees for asset-intensive sectors, governmental procurement, and product pricing. In the face of ever-stronger competition, if the US is to retain its leading position in the life sciences, public policy must consider competition among nations as well as among firms. This article analyzes emerging innovation and industrial policy in the three principal sectors in the life sciences: research universities and laboratories; entrepreneurial startups and "scale-ups," and large pharmaceutical and medical device corporations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Biological Science DisciplinesHumansCOVID-19 VaccinesOrganizationsPolicyChina

Stichwörter der Autor:innen

ChinaMedical devicescompetitionindustrial policyinnovationpharmaceuticalsresearch and developmentventure capital

Substanzen

COVID-19 Vaccines

Autor:innen und Institutionen

  • James C. Robinson (james.robinson@berkeley.edu), University of California Berkeley, Berkeley, California.

Zitieren

APA

Robinson, J. C. (2023). How Industrial Policy Could Accelerate Innovation In The Life Sciences. Health Affairs. https://doi.org/10.1377/hlthaff.2023.00047

Vancouver

Robinson JC. How Industrial Policy Could Accelerate Innovation In The Life Sciences. Health Affairs. 2023. doi:10.1377/hlthaff.2023.00047

BibTeX
@article{Robinson2023,
  author = {Robinson, James C},
  title = {How Industrial Policy Could Accelerate Innovation In The Life Sciences},
  journal = {Health Affairs},
  year = {2023},
  doi = {10.1377/hlthaff.2023.00047}
}
Kostenlos starten →